BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15386802)

  • 1. Regulatory T-cells in type 1 diabetes.
    Juedes AE; von Herrath MG
    Diabetes Metab Res Rev; 2004; 20(6):446-51. PubMed ID: 15386802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice.
    Piccirillo CA; Tritt M; Sgouroudis E; Albanese A; Pyzik M; Hay V
    Ann N Y Acad Sci; 2005 Jun; 1051():72-87. PubMed ID: 16126946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in type I diabetes associated tolerance mechanisms.
    Chentoufi AA; Binder NR; Berka N; Abunadi T; Polychronakos C
    Scand J Immunol; 2008 Jul; 68(1):1-11. PubMed ID: 18482207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [B cells as key contributors in determining the level of immune responses -B-cell-targeted therapy in patients with autoimmune diseases].
    Kondo S; Akashi T; Katsuta H; Iwakiri R; Anzai K; Nagafuchi S; Niho Y; Harada M
    Fukuoka Igaku Zasshi; 2005 Apr; 96(4):86-92. PubMed ID: 15991605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The natural killer T lymphocyte: a player in the complex regulation of autoimmune diabetes in non-obese diabetic mice.
    Cardell SL
    Clin Exp Immunol; 2006 Feb; 143(2):194-202. PubMed ID: 16412042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune mechanisms in type 1 diabetes.
    Knip M; Siljander H
    Autoimmun Rev; 2008 Jul; 7(7):550-7. PubMed ID: 18625444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional waning of naturally occurring CD4+ regulatory T-cells contributes to the onset of autoimmune diabetes.
    Tritt M; Sgouroudis E; d'Hennezel E; Albanese A; Piccirillo CA
    Diabetes; 2008 Jan; 57(1):113-23. PubMed ID: 17928397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexpression of CD25 and OX40 (CD134) receptors delineates autoreactive T-cells in type 1 diabetes.
    Endl J; Rosinger S; Schwarz B; Friedrich SO; Rothe G; Karges W; Schlosser M; Eiermann T; Schendel DJ; Boehm BO
    Diabetes; 2006 Jan; 55(1):50-60. PubMed ID: 16380476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficiency in NOD antigen-presenting cell function may be responsible for suboptimal CD4+CD25+ T-cell-mediated regulation and type 1 diabetes development in NOD mice.
    Alard P; Manirarora JN; Parnell SA; Hudkins JL; Clark SL; Kosiewicz MM
    Diabetes; 2006 Jul; 55(7):2098-105. PubMed ID: 16804081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoreactive T cells in endocrine/organ-specific autoimmunity: why has progress been so slow?
    Roep BO
    Springer Semin Immunopathol; 2002 Dec; 24(3):261-71. PubMed ID: 12503054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of type 1 diabetes by CD4+Foxp3+ regulatory T cells: lessons from mouse models and implications for human disease.
    Sgouroudis E; Piccirillo CA
    Diabetes Metab Res Rev; 2009 Mar; 25(3):208-18. PubMed ID: 19214972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of local production of cytokines in the pathogenesis of insulin-dependent diabetes mellitus.
    Falcone M; Sarvetnick N
    Clin Immunol; 1999 Jan; 90(1):2-9. PubMed ID: 9884346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoreactive T cell response in CD25-negative fraction of peripheral blood mononuclear cells in established type 1 diabetes.
    Moriyama H; Kotani R; Katsuta A; Kameno M; Arai T; Okumachi Y; Kishi M; Yamada K; Yasuda H; Hara K; Yokono K; Nagata M
    Ann N Y Acad Sci; 2008 Dec; 1150():278-81. PubMed ID: 19120313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory T cells: development, function and role in autoimmunity.
    Lan RY; Ansari AA; Lian ZX; Gershwin ME
    Autoimmun Rev; 2005 Jul; 4(6):351-63. PubMed ID: 16081026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes.
    Pinkse GG; Tysma OH; Bergen CA; Kester MG; Ossendorp F; van Veelen PA; Keymeulen B; Pipeleers D; Drijfhout JW; Roep BO
    Proc Natl Acad Sci U S A; 2005 Dec; 102(51):18425-30. PubMed ID: 16339897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoregulation of autoimmunity by natural killer T cells.
    Linsen L; Somers V; Stinissen P
    Hum Immunol; 2005 Dec; 66(12):1193-202. PubMed ID: 16690406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-beta and T-cell-mediated immunoregulation in the control of autoimmune diabetes.
    You S; Thieblemont N; Alyanakian MA; Bach JF; Chatenoud L
    Immunol Rev; 2006 Aug; 212():185-202. PubMed ID: 16903915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysrulation of T cell peripheral tolerance in type 1 diabetes.
    Tisch R; Wang B
    Adv Immunol; 2008; 100():125-49. PubMed ID: 19111165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory T cells and type 1 diabetes.
    Homann D; von Herrath M
    Clin Immunol; 2004 Sep; 112(3):202-9. PubMed ID: 15308110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
    Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
    Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.